• Press Releases.png

    Press Releases

OmniComm Systems® Expands Resources for Rapidly Growing Early Phase Market

September 07, 2016


Dennis Constantinou
OmniComm Systems, Inc.

Download Press Release

Fort Lauderdale, FL, September 07, 2016 - OmniComm Systems, Inc. (OmniComm) (OTCQX: OMCM), a global leading provider of clinical data management technology, today announces the appointments of Jessica Ekey as executive director of early phase consulting, Laura M. Fraser as senior director of early phase consulting, and Roman Laddach as director of early phase consulting.

“We are pleased to welcome Jessica, Laura, and Roman to the OmniComm team,” said Ken Light EVP of Transformation and Professional Services for OmniComm.  “With the addition of these three talented leaders and subject matter experts, we are strengthening our ability to provide our clients with the solutions and support required to have an immediate and measurable impact on their phase one clinic operations.  We look forward to leveraging the skills and experience of Jessica, Laura and Roman to drive growth for OmniComm in the months and years to come.”

In her new role as executive director of early phase consulting, Jessica will collaborate with the TrialOne® development team in the development and application of the TrialOne product and services roadmap.  Prior to joining OmniComm, Jessica served as the associate director of clinical systems for Quintiles.  Her role included leading their clinical technology strategy.  Jessica has over ten years of experience at Quintiles in various roles of increasing responsibility.

As OmniComm’s new senior director of early phase consulting, Laura will work closely with the TrialOne team and clients to spearhead the coordination and implementation of TrialOne.  Before joining OmniComm, Laura served as a bedside data capture business lead and project manager at Covance. During her 11 years with Covance, Laura supervised the subject recruitment and screening department and, as a Six Sigma Black Belt, she led multiple process improvement teams.

In his role as director of early phase consulting, Roman will assist OmniComm’s TrialOne clients realize the full potential of TrialOne.  In his former role, Roman served as clinical systems specialist for Quintiles’ early phase clinic in London, where he led the successful implementation of TrialOne. In addition, Roman has served as a clinical research technician at Quintiles where he served for a period of six years.

These new hires join OmniComm as the company builds on the momentum it has achieved with TrialOne that includes global top tier pharmaceutical, contract research organization (CRO), academic research and early phase clinic organizations.

TrialOne is widely recognized as the market leading early phase clinic automation and eSource solution among early phase research centers. TrialOne is a browser-based bedside data collection technology specifically designed to automate the workflows and processes within early phase research clinics.

TrialOne’s unique capabilities include:

  • Management and optimization of patient screening and recruitment
  • Comprehensive eSource from paper source records
  • Tablet based data capture from subject bedside
  • Automated data capture from medical monitoring equipment and devices
  • Streamlined staff training and support records
  • Integration with laboratory information management systems (LIMS) for lab orders and lab results processing

TrialOne enables the automation of clinic data collection; standardizes recruiting; facilitates the collection of study data and sample tracking; reduces discrepancies inherent in paper-based applications; and ensures compliance.

About OmniComm Systems, Inc.
OmniComm Systems, Inc. is a leading strategic software solutions provider to the life sciences industry. OmniComm is dedicated to helping the world’s pharmaceutical, biotechnology, contract research organizations, diagnostic and device firms, and academic medical centers maximize the value of their clinical research investments. Through the use of innovative and progressive technologies these organizations drive efficiency in clinical development, better manage their risks, ensure regulatory compliance and manage their clinical operations performance. OmniComm provides comprehensive solutions for clinical research with an extensive global experience from over 4,800 clinical trials. For more information, visit www.omnicomm.com.

OmniComm, TrialMaster, TrialOne, and Promasys are registered trademarks of OmniComm Systems, Inc. Other names may be trademarks of their respective owners.

Topics: Phase I